Odyssey Therapeutics, Inc. , a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the appointment of Darryl Patrick , D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development.
May 24, 2022
· 4 min read